Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality

Archives of Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 7, 2010, Pages 692-696

  Salter, Kelli D ^a   Andersen, Peter E ^a   Cohen, James I ^c   Schuff, Kathyrn G ^b   Lester, Linda ^b   Shindo, Maisie L ^a   Sauer, David ^a   Gross, Neil D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Portland Veterans Affair Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER SIZE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; PAPILLARY THYROID CARCINOMA; PROGNOSIS; RETROSPECTIVE STUDY; SEX RATIO; THYROID CARCINOMA;

ACADEMIC MEDICAL CENTERS; BIOPSY, NEEDLE; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 77954979767     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2010.112     Document Type: Article

References (25)

1. Sherman SI. Thyroid carcinoma. Lancet. 2003;361(9356):501-511.
2. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer. 1998;83(12):2638-2648.
3. Caron NR, Clark OH. Well differentiated thyroid cancer. Scand J Surg. 2004;93(4):261-271.
4. Grebe SK, Hay ID. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am. 1996;5(1):43-63.
5. Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg. 1994;18(4):559-567.
6. Wang TS, Dubner S, Sznyter LA, Heller KS. Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes. Arch Otolaryngol Head Neck Surg. 2004;130(1):110-113.
7. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid: prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98(1):31-40.
8. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992;112(6):1139-1146.
9. Qubain SW, Nakano S, Baba M, Takao S, Aikou T. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery. 2002;131(3):249-256.
10. Arturi F, Russo D, Giuffrida D, et al. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab. 1997;82(5):1638-1641.
11. Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237(3):399-407.
12. Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002;26(1):22-28.
13. Gimm O, Rath FW, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg. 1998;85(2):252-254.
14. White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg. 2007;31(5):895-904.
15. Shindo M, Wu JC, Park EE, Tanzella F. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2006;132(6):650-654.
16. Grodski S, Cornford L, Sywak M, Sidhu S, Delbridge L. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg. 2007;77(4):203-208.
17. Cooper DS, Doherty GM, Haugen BR, et al; American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16(2):109-142.
18. Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope. 2004;114(3):393-402.
19. Shaha AR. Management of the neck in thyroid cancer. Otolaryngol Clin North Am. 1998;31(5):823-831.
20. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97(5):418-428.
21. Robbins KT, Clayman G, Levine PA, et al; American Head and Neck Society; American Academy of Otolaryngology - Head and Neck Surgery. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology - Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002;128(7):751-758.
22. Schlumberger M, Challeton C, DeVathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastasis from thyroid carcinoma. J Nucl Med. 1996;37(4):598-605.
23. Jonklaas J. Role of radioactive iodine for adjuvant therapy and treatment of metastases. J Natl Compr Canc Netw. 2007;5(6):631-640.
24. Sawka AM, Brierley JD, Tsang RW, et al. An updated systemic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am. 2008;37(2):457-480.
25. Ganti AK, Cohen EE. Iodine-refractory thyroid carcinoma. Rev Recent Clin Trials. 2006;1(2):133-141.